Gd-EOB-DTPA as a functional MR cholangiography contrast agent: Imaging gallbladder filling in patients with and without hepatobiliary dysfunction

Journal of Computer Assisted Tomography

Volumn 35, Issue 4, 2011, Pages 439-445

  Smith, Andrew Dennis ^a   Veniero, Joseph C ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Eovist; fMRC; functional magnetic resonance cholangiography; gallbladder; Gd EOB DTPA; MRC

Indexed keywords

BIOLOGICAL ORGANS; DUCTS; MAGNETISM; RESONANCE; SEARCH ENGINES;

DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; EOVIST; FMRC; FUNCTIONAL MAGNETIC RESONANCE CHOLANGIOGRAPHY; GADOLINIA; GADOLINIA ETHOXYBENZYL DIETHYLENETRIAMINE PENTAACETIC ACID; GALLBLADDER; HEPATOBILIARY; MAGNETIC RESONANCE CHOLANGIOGRAPHY; MRC;

MAGNETIC RESONANCE IMAGING;

BILIRUBIN; ECHOVIST;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BIOACCUMULATION; CHOLELITHIASIS; CONTRAST ENHANCEMENT; DRUG ACCUMULATION; FEMALE; FUNCTIONAL ASSESSMENT; GALLBLADDER; GALLBLADDER CONTRACTION; HEPATOBILIARY DISEASE; HUMAN; INTRAVENOUS CHOLANGIOGRAPHY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAGNETIC RESONANCE CHOLANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 80051512231     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31821f4e29     Document Type: Article

References (24)

1. Strasberg SM. Clinical practice: acute calculous cholecystitis. N Engl JMed. 2008;358:2804-2811.
2. Stoker J, van Randen A, Laméris W, et al. Imaging patients with acute abdominal pain. Radiology. 2009;253:31-46.
3. Trowbridge RL, Rutkowski NK, Shojania KG. Does this patient have acute cholecystitis? JAMA. 2003;289:80-86. (Pubitemid 36026282)
4. Park MS, Yu JS, Kim MJ, et al. Acute cholecystitis: comparison of MR cholangiography and US. Radiology. 1998;209:781-785.
5. Akpinar E, Turkbey B, Karcaaltincaba M, et al. Initial experience on utility ofgadobenate dimeglumine (Gd-BOPTA) enhancedT1-weighted MR cholangiography in diagnosis ofacute cholecystitis. JMagn Reson Imaging. 2009;30:578-585.
6. Kim KW, Park M, Yu PC, et al. Acute cholecystitis at T2-weighted and manganese-enhanced T2-weighted MR cholangiography: preliminary study. Radiology. 2003;227:580-584. (Pubitemid 36514781)
7. Fayad LM, Holland GA, Bergin D, et al. Functional and anatomic evaluation of the gallbladder and biliary tree with mangafodipir trisodium-enhanced functional magnetic resonance cholangiography (fMRC). JMagn Reson Imaging. 2003;18:449-460. (Pubitemid 37187598)
8. Fayad LM, Kamel IR, Mitchell DG, et al. Functional MR cholangiography: diagnosis offunctional abnormalities of the gallbladder and biliary tree. AJR Am J Roentgenol. 2005;184: 1563-1571. (Pubitemid 43821836)
9. Asbach P, Warmuth C, Stemmer A, et al. High spatial resolution T1-weighted MR imaging of the liver and biliary tract during uptake phase of a hepatocyte-specific contrast medium. Invest Radiol. 2008;43:809-815.
10. Dahlstrom N, Persson A, Albiin N, et al. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Acta Radiol. 2007;48:362-368. (Pubitemid 46633865)
11. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 1992;183:59-64.
12. Bollow M, Taupitz M, Hamm B, et al. Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-1 clinical evaluation. Eur Radiol. 1997;7:126-132. (Pubitemid 127538537)
13. Tschirch FT, Struwe A, Petrowsky H, et al. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liverparenchyma. EurRadiol. 2008;18:1577-1586.
14. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864-871. (Pubitemid 30169932)
15. Koelblinger C, Schima W, Weber M, et al. Gadoxate-enhanced T1-weighted MR cholangiography: comparison of 1.5 T and 3.0 T. Rofo. 2009;181:587-592.
16. Choy D, Shi EC, McLean RG, et al. Cholescintigraphy in acute cholecystitis: use of intravenous morphine. Radiology. 1984;151: 203-207. (Pubitemid 14170025)
17. Carlos RC, Branam JD, Dong Q, et al. Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? Acad Radiol. 2002;9:1322-1325. (Pubitemid 35265403)
18. Carlos RC, Hussain HK, Song JH, et al. Gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. AJR Am JRoentgenol. 2002;179:87-92. (Pubitemid 34694816)
19. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology. 1995;195:785-792.
20. Kato N, Takahashi M, Ihara S, et al. Efficacy and safety of liver-specific MRI contrast agents in rats with hepatitis and cirrhosis. Acad Radiol. 1998;5:S83-S85.
21. Weinmann HJ, Bauer H, Frenzel T, et al. Mechanism ofhepatic uptake ofgadohexate disodium. AcadRadiol. 1996;3:S232-S234.
22. Costi R, Sarli L, Caruso G, et al. Preoperative ultrasonographic assessment of the number and size ofgallbladder stones: is it a useful predictor ofasymptomatic choledochal lithiasis? J UltrasoundMed. 2002;21:971-976. (Pubitemid 34988603)
23. Williams EJ, Green J, Beckingham I, et al. Guidelines on the management of common bile duct stones (CBDS). Gut. 2008;57: 1004-1021. (Pubitemid 351919536)
24. Eshghi F, Abdi R. Routine magnetic resonance cholangiography compared to intra-operative cholangiography in patients with suspected common bile duct stones. Hepatobiliary Pancreat Dis Int. 2008;7: 525-528.